Five Supplement Categories Set to Dominate 2027: What B2B Buyers Should Stock Now
Buying decisions made this quarter determine next year's best-sellers. Based on marketplace search velocity, social listening and our own order flow from 200+ private label clients, five categories show the strongest signals heading into 2027.
1. Longevity & NAD+ — From Biohackers to Mainstream
NAD+ precursors (NMN/NR), resveratrol and urolithin-A have crossed from niche biohacker forums into mainstream retail. Search volume for "NAD supplement" has grown steadily for three consecutive years, and pharmacy chains are now allocating shelf space.
- Entry point: single-ingredient NAD+ or resveratrol capsules
- Premium point: multi-mechanism complexes (NAD+ + resveratrol + urolithin-A)
- Buyer note: bioavailability claims (liposomal forms) justify 30–50% price premiums
2. Women's Creatine — The Fastest-Growing Creatine Segment
Creatine was historically marketed almost exclusively to men. That's changing fast: women's-specific formulations pairing creatine with collagen, biotin and hyaluronic acid are converting buyers who would never touch a "gym bro" tub.
The pitch writes itself — muscle tone plus beauty in one scoop. Early movers in this segment are still locking in search rankings; the window is open but closing.
3. Sleep Gummies — The Post-Pandemic Permanent Need
Melatonin gummies keep double-digit growth with no plateau signal. The gummy format drives compliance, and compliance drives reviews. Drug-free positioning keeps regulatory exposure low in most markets.
4. Functional Mushrooms — Focus Without the Crash
Lion's mane, cordyceps and reishi have moved from smoothie shops to Walmart shelves. Mushroom coffee remains the flagship format because it replaces a habit rather than adding one.
5. Gut Health Beyond Probiotics
Probiotics are table stakes now. The growth is in adjacent SKUs: Akkermansia muciniphila (the frontier strain), candida cleanse protocols, and fiber-forward greens powders with taste that survives daily use.